Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Side effects analyses in consideration of renal function for S-1-administered patients]Mina Iwai, Michio Kimura, Tomoaki Yoshimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 16, 2012
[Side effect analyses in consideration of renal functions for capecitabine-administered patients]Mina Iwai, Michio Kimura, Tomoaki Yoshimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 8, 2022
[Comparative Safety Assessment of Ramucirumab plus FOLFIRI and Bevacizumab plus FOLFIRI in Second- and Later-Line Treatment in Japanese Patients with Metastatic Colorectal Carcinoma]Mina Iwai, Michio Kimura, Eiseki Usami, et al.
Anticancer Research|November 29, 2025
Determining Candidate D-dimer Thresholds for Lower-extremity Ultrasound in Monitoring Deep Vein Thrombosis in Patients With Gastric Cancer Receiving RamucirumabShoya Takenaka, Michio Kimura, Mina Iwai, et al.
In Vivo (Athens, Greece)|August 28, 2016
Prophylactic Efficacy Against Herpes Zoster and Costs Difference Between Acyclovir and Valaciclovir in Hematological PatientsEiseki Usami, Michio Kimura, Mina Iwai, et al.
Molecular and Clinical Oncology|June 8, 2017
Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicaseEiseki Usami, Michio Kimura, Mina Iwai, et al.
Molecular and Clinical Oncology|May 19, 2017
Pharmaco-economic analysis of adjuvant chemotherapy for stage II and III colorectal cancerMina Iwai, Michio Kimura, Eiseki Usami, et al.
Molecular and Clinical Oncology|April 14, 2016
Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient settingEiseki Usami, Michio Kimura, Mina Iwai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 22, 2024
[Investigation of Factors Related to Overall Survival in Patients Treated with Gemcitabine plus Paclitaxel(Albumin Suspension)for Advanced or Recurrent Pancreatic Cancer]Daisuke Ito, Shoya Takenaka, Akihiro Moriya, et al.
Molecular and Clinical Oncology|December 1, 2016
Comparison of cost-effectiveness of regorafenib and trifluridine/tipiracil combination tablet for treating advanced and recurrent colorectal cancerMichio Kimura, Eiseki Usami, Mina Iwai, et al.
Pageof 3